Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia

Varghese, AM, Rawstron, A orcid.org/0000-0003-0798-9790, Newton, D orcid.org/0000-0002-0214-1486 et al. (5 more authors) (2018) Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia. British Journal of Haematology, 182 (6). pp. 927-930. ISSN 0007-1048

Metadata

Authors/Creators:
Dates:
  • Published (online): 2 August 2017
  • Published: September 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Aug 2017 10:04
Last Modified: 12 Sep 2018 14:22
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/bjh.14884

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics